whereas symptomatic CMV disease was not different between groups (5.6% vs 5.8%, P = 1.00), [2 (1 hepatitis and 1 colitis) In pre-emptive vs 3 (2 pneumonia and 1 syndrome)].… Click to show full abstract
whereas symptomatic CMV disease was not different between groups (5.6% vs 5.8%, P = 1.00), [2 (1 hepatitis and 1 colitis) In pre-emptive vs 3 (2 pneumonia and 1 syndrome)]. Under pre-emptive strategy, patients with CMV infection were more likely to be older [(49.6 vs 41 Years old), P = 0.04], and have longer time on dialysis prior to KT [(6.2 vs 4.2 years), P = 0.01], compared to those not receiving.
               
Click one of the above tabs to view related content.